Report Detail
Global Nuclear Pharmacy Market Growth (Status and Outlook) 2022-2028
- RnM4494796 |
- 04 November, 2022 |
- Global |
- 89 Pages |
- LPI(LP Information) |
- Other
The global market for Nuclear Pharmacy is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Nuclear Pharmacy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Nuclear Pharmacy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Nuclear Pharmacy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Nuclear Pharmacy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Nuclear Pharmacy players cover PharmaLogic, Nihon Medi-Physics, Yantai Dongcheng Biochemicals, Curium Pharma and Cardinal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Nuclear Pharmacy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Nuclear Pharmacy market, with both quantitative and qualitative data, to help readers understand how the Nuclear Pharmacy market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Nuclear Pharmacy market and forecasts the market size by Type (Diagnostic Products and Therapeutic Products,), by Application (Pharmaceutical, Hospital and Laboratory,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Diagnostic Products
Therapeutic Products
Segmentation by application
Pharmaceutical
Hospital
Laboratory
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
PharmaLogic
Nihon Medi-Physics
Yantai Dongcheng Biochemicals
Curium Pharma
Cardinal Health
Jubilant Radiopharma
GE Healthcare
UPPI
Chapter Introduction
Chapter 1: Scope of Nuclear Pharmacy, Research Methodology, etc.
Chapter 2: Executive Summary, global Nuclear Pharmacy market size and CAGR, Nuclear Pharmacy market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Nuclear Pharmacy revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Nuclear Pharmacy revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Nuclear Pharmacy market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including PharmaLogic, Nihon Medi-Physics, Yantai Dongcheng Biochemicals, Curium Pharma, Cardinal Health, Jubilant Radiopharma, GE Healthcare and UPPI, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nuclear Pharmacy Market Size 2017-2028
- 2.1.2 Nuclear Pharmacy Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Nuclear Pharmacy Segment by Type
- 2.2.1 Diagnostic Products
- 2.2.2 Therapeutic Products
- 2.3 Nuclear Pharmacy Market Size by Type
- 2.3.1 Nuclear Pharmacy Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Nuclear Pharmacy Market Size Market Share by Type (2017-2022)
- 2.4 Nuclear Pharmacy Segment by Application
- 2.4.1 Pharmaceutical
- 2.4.2 Hospital
- 2.4.3 Laboratory
- 2.5 Nuclear Pharmacy Market Size by Application
- 2.5.1 Nuclear Pharmacy Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Nuclear Pharmacy Market Size Market Share by Application (2017-2022)
3 Nuclear Pharmacy Market Size by Player
- 3.1 Nuclear Pharmacy Market Size Market Share by Players
- 3.1.1 Global Nuclear Pharmacy Revenue by Players (2020-2022)
- 3.1.2 Global Nuclear Pharmacy Revenue Market Share by Players (2020-2022)
- 3.2 Global Nuclear Pharmacy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Nuclear Pharmacy by Regions
- 4.1 Nuclear Pharmacy Market Size by Regions (2017-2022)
- 4.2 Americas Nuclear Pharmacy Market Size Growth (2017-2022)
- 4.3 APAC Nuclear Pharmacy Market Size Growth (2017-2022)
- 4.4 Europe Nuclear Pharmacy Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Nuclear Pharmacy Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Nuclear Pharmacy Market Size by Country (2017-2022)
- 5.2 Americas Nuclear Pharmacy Market Size by Type (2017-2022)
- 5.3 Americas Nuclear Pharmacy Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Nuclear Pharmacy Market Size by Region (2017-2022)
- 6.2 APAC Nuclear Pharmacy Market Size by Type (2017-2022)
- 6.3 APAC Nuclear Pharmacy Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Nuclear Pharmacy by Country (2017-2022)
- 7.2 Europe Nuclear Pharmacy Market Size by Type (2017-2022)
- 7.3 Europe Nuclear Pharmacy Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Nuclear Pharmacy by Region (2017-2022)
- 8.2 Middle East & Africa Nuclear Pharmacy Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Nuclear Pharmacy Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Nuclear Pharmacy Market Forecast
- 10.1 Global Nuclear Pharmacy Forecast by Regions (2023-2028)
- 10.1.1 Global Nuclear Pharmacy Forecast by Regions (2023-2028)
- 10.1.2 Americas Nuclear Pharmacy Forecast
- 10.1.3 APAC Nuclear Pharmacy Forecast
- 10.1.4 Europe Nuclear Pharmacy Forecast
- 10.1.5 Middle East & Africa Nuclear Pharmacy Forecast
- 10.2 Americas Nuclear Pharmacy Forecast by Country (2023-2028)
- 10.2.1 United States Nuclear Pharmacy Market Forecast
- 10.2.2 Canada Nuclear Pharmacy Market Forecast
- 10.2.3 Mexico Nuclear Pharmacy Market Forecast
- 10.2.4 Brazil Nuclear Pharmacy Market Forecast
- 10.3 APAC Nuclear Pharmacy Forecast by Region (2023-2028)
- 10.3.1 China Nuclear Pharmacy Market Forecast
- 10.3.2 Japan Nuclear Pharmacy Market Forecast
- 10.3.3 Korea Nuclear Pharmacy Market Forecast
- 10.3.4 Southeast Asia Nuclear Pharmacy Market Forecast
- 10.3.5 India Nuclear Pharmacy Market Forecast
- 10.3.6 Australia Nuclear Pharmacy Market Forecast
- 10.4 Europe Nuclear Pharmacy Forecast by Country (2023-2028)
- 10.4.1 Germany Nuclear Pharmacy Market Forecast
- 10.4.2 France Nuclear Pharmacy Market Forecast
- 10.4.3 UK Nuclear Pharmacy Market Forecast
- 10.4.4 Italy Nuclear Pharmacy Market Forecast
- 10.4.5 Russia Nuclear Pharmacy Market Forecast
- 10.5 Middle East & Africa Nuclear Pharmacy Forecast by Region (2023-2028)
- 10.5.1 Egypt Nuclear Pharmacy Market Forecast
- 10.5.2 South Africa Nuclear Pharmacy Market Forecast
- 10.5.3 Israel Nuclear Pharmacy Market Forecast
- 10.5.4 Turkey Nuclear Pharmacy Market Forecast
- 10.5.5 GCC Countries Nuclear Pharmacy Market Forecast
- 10.6 Global Nuclear Pharmacy Forecast by Type (2023-2028)
- 10.7 Global Nuclear Pharmacy Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 PharmaLogic
- 11.1.1 PharmaLogic Company Information
- 11.1.2 PharmaLogic Nuclear Pharmacy Product Offered
- 11.1.3 PharmaLogic Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 PharmaLogic Main Business Overview
- 11.1.5 PharmaLogic Latest Developments
- 11.2 Nihon Medi-Physics
- 11.2.1 Nihon Medi-Physics Company Information
- 11.2.2 Nihon Medi-Physics Nuclear Pharmacy Product Offered
- 11.2.3 Nihon Medi-Physics Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Nihon Medi-Physics Main Business Overview
- 11.2.5 Nihon Medi-Physics Latest Developments
- 11.3 Yantai Dongcheng Biochemicals
- 11.3.1 Yantai Dongcheng Biochemicals Company Information
- 11.3.2 Yantai Dongcheng Biochemicals Nuclear Pharmacy Product Offered
- 11.3.3 Yantai Dongcheng Biochemicals Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Yantai Dongcheng Biochemicals Main Business Overview
- 11.3.5 Yantai Dongcheng Biochemicals Latest Developments
- 11.4 Curium Pharma
- 11.4.1 Curium Pharma Company Information
- 11.4.2 Curium Pharma Nuclear Pharmacy Product Offered
- 11.4.3 Curium Pharma Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Curium Pharma Main Business Overview
- 11.4.5 Curium Pharma Latest Developments
- 11.5 Cardinal Health
- 11.5.1 Cardinal Health Company Information
- 11.5.2 Cardinal Health Nuclear Pharmacy Product Offered
- 11.5.3 Cardinal Health Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Cardinal Health Main Business Overview
- 11.5.5 Cardinal Health Latest Developments
- 11.6 Jubilant Radiopharma
- 11.6.1 Jubilant Radiopharma Company Information
- 11.6.2 Jubilant Radiopharma Nuclear Pharmacy Product Offered
- 11.6.3 Jubilant Radiopharma Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Jubilant Radiopharma Main Business Overview
- 11.6.5 Jubilant Radiopharma Latest Developments
- 11.7 GE Healthcare
- 11.7.1 GE Healthcare Company Information
- 11.7.2 GE Healthcare Nuclear Pharmacy Product Offered
- 11.7.3 GE Healthcare Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 GE Healthcare Main Business Overview
- 11.7.5 GE Healthcare Latest Developments
- 11.8 UPPI
- 11.8.1 UPPI Company Information
- 11.8.2 UPPI Nuclear Pharmacy Product Offered
- 11.8.3 UPPI Nuclear Pharmacy Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 UPPI Main Business Overview
- 11.8.5 UPPI Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nuclear Pharmacy. Industry analysis & Market Report on Nuclear Pharmacy is a syndicated market report, published as Global Nuclear Pharmacy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nuclear Pharmacy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
